| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.4M | — | -0.7% |
| Cost of Revenue | $5.7M | — | -8.0% |
| Gross Profit | $16.7M | — | +2.1% |
| R&D Expense | $6.2M | — | +10.2% |
| SG&A Expense | $6.8M | — | -1.6% |
| Operating Income | -$3.3M | — | +46.9% |
| Pre-tax Income | -$2.2M | — | +54.8% |
| Income Tax | $4K | — | +0.0% |
| Net Income | -$2.2M | — | +54.8% |
| EPS (Basic) | -$0.06 | — | +57.1% |
| EPS (Diluted) | -$0.06 | — | +57.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.3M | -11.2% | +0.1% |
| Accounts Receivable | $647K | +53.3% | -1.7% |
| Current Assets | $93.4M | -8.7% | -15.0% |
| Total Assets | $121.8M | -7.8% | -14.5% |
| Current Liabilities | $24.9M | +2.1% | -15.2% |
| Total Liabilities | $37.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.1M | — | +1203.1% |
| Capital Expenditures | $232K | — | +393.6% |
| Investing Cash Flow | $6.8M | — | +307.3% |
| Financing Cash Flow | -$10.3M | — | -327.1% |
| Free Cash Flow | $827K | — | +678.3% |
| -18.1% |
| Stockholders' Equity | $84.0M | -10.3% | -12.8% |